New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
10:07 EDTQCOR, RTRXRetrophin CEO says suit filed against Questcor
On his official Twitter account, Martin Shkreli, þthe CEO of Retrophin (RTRX), announced his company filed an antitrust lawsuit against Questcor (QCOR) in California last night. Shares of Questcor are down 5% to $50.46 in early trading. Reference Link
News For RTRX;QCOR From The Last 14 Days
Check below for free stories on RTRX;QCOR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2014
10:58 EDTQCORPaulson action positive for Mallinckrodt, Questcor, says BMO Capital
BMO Capital said Paulson & Co. being granted an option to increase its stake in Mallinckrodt (MNK) to 20% will be viewed by the market as a bullish sign and points to the Questcor (QCOR) acquisition likely being completed. BMO also believes Paulson's position could also provide a defense mechanism if a hostile bid were made on Mallinckrodt. The firm maintains an Outperform rating on Mallinckrodt.
09:42 EDTQCORMallinckrodt increases Paulson & Co. threshold to 20% from 10%
Subscribe for More Information
April 21, 2014
09:02 EDTQCORQuestcor's Acthar shows positive results in clinical study
Subscribe for More Information
07:26 EDTQCORQuestcor shares can advance significantly, says Oppenheimer
Subscribe for More Information
06:14 EDTQCORStocks with implied volatility below IV index mean; QCOR MNKD
Subscribe for More Information
April 17, 2014
09:32 EDTQCORLeerink's specialty pharma/generics analyst has analyst/industry conference call
Subscribe for More Information
03:54 EDTQCORStocks with implied volatility below IV index mean; QCOR MNKD
Stocks with implied volatility below IV index mean; Questcor (QCOR) 47, MannKind (MNKD) 82 according to iVolatility.
April 16, 2014
06:23 EDTQCOR Stocks with implied volatility below IV index mean; QCOR MNKD
Subscribe for More Information
April 15, 2014
07:42 EDTQCORFDA received two documents questioning Acthar, says Jefferies
Subscribe for More Information
06:04 EDTQCORStocks with implied volatility below IV index mean; QCOR MNKD
Subscribe for More Information
April 14, 2014
16:24 EDTRTRXOn The Fly: Closing Wrap
Subscribe for More Information
07:10 EDTRTRXRetrophin disappointed FDA won't grant expedited access to RE-024 for children
On Friday, April 11, Retrophin received an update from RE-024 clinical investigators that, despite several investigator-sponsored IND filings for RE-024 in the United States, the FDA has been unwilling to grant a clinical trial through this mechanism. The company intends to file a company-sponsored IND in May or June 2014, with a Phase I clinical trial in PKAN patients beginning in June or July 2014. The company continues to support efforts to launch an investigator-sponsored trial outside of the United States. The company said, “While we are disappointed the FDA has been unwilling to grant expedited access to RE-024 for children with a lethal disease, we respect its decision and are motivated by the enthusiastic and brave physicians and patients who desperately want access to this promising molecule. The small delay is frustrating to all of our stakeholders, but we expect the issue will be resolved in the near term and we are taking steps to grow our R&D infrastructure to avoid similar experiences in the future.”
07:09 EDTRTRXRetrophin raises FY14 revenue view to $19M-$21M from $10M-$12M
Subscribe for More Information
05:54 EDTQCORStocks with implied volatility below IV index mean; QCOR MNKD
Stocks with implied volatility below IV index mean; Questcor (QCOR) 44, MannKind (MNKD) 83 according to iVolatility.
April 11, 2014
10:46 EDTQCOROptions with decreasing implied volatility: MNKD QCOR NQ WWE BBBY
06:04 EDTQCORStocks with implied volatility below IV index mean; QCOR MNKD
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use